Merus B.v.
Clinical trials sponsored by Merus B.v., explained in plain language.
-
New drug trial offers hope for Tough-to-Treat head and neck cancers
Disease control Recruiting nowThis study is testing an experimental drug called petosemtamab for people with advanced head and neck cancer that has spread or returned after standard treatments. It will compare petosemtamab against other single-drug treatments chosen by doctors to see which works better. The m…
Phase: PHASE3 • Sponsor: Merus B.V. • Aim: Disease control
Last updated Apr 04, 2026 03:20 UTC
-
New drug duo battles tough head and neck cancer in major trial
Disease control Recruiting nowThis study is testing whether adding a new drug called petosemtamab to the standard treatment (pembrolizumab) works better for people with advanced head and neck cancer that has returned or spread. It will involve about 500 adults who have not yet received treatment for their adv…
Phase: PHASE3 • Sponsor: Merus B.V. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New Two-Drug attack on advanced lung cancer enters testing
Disease control Recruiting nowThis study is testing whether adding a new drug called petosemtamab to an existing immunotherapy (pembrolizumab) is safe and more effective for people newly diagnosed with advanced non-small cell lung cancer. It will involve about 180 adults whose cancer has spread and who have n…
Phase: PHASE2 • Sponsor: Merus B.V. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC